Publicaciones en las que colabora con MARÍA LUISA SAYALERO MARINERO (20)

2014

  1. Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 955-956, Núm. 1, pp. 93-97

2012

  1. Cell-based drug-delivery platforms

    Therapeutic Delivery, Vol. 3, Núm. 1, pp. 25-41

2011

  1. Desarrollo y aplicación de recursos audiovisuales docentes en el área de farmacia y tecnología farmacéutica

    Primeras Jornadas de Innovación Docente en la Universidad de Salamanca

2006

  1. Cells and cell ghosts as drug carriers

    Nanoparticulates as Drug Carriers (Imperial College Press), pp. 329-348

2005

  1. Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes

    Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, Vol. 12, Núm. 6, pp. 409-416

2004

  1. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis

    Blood Cells, Molecules, and Diseases, Vol. 33, Núm. 2, pp. 132-140

2002

  1. Determination of Amikacin in biological tissues by HPLC

    Journal of Liquid Chromatography and Related Technologies, Vol. 25, Núm. 2, pp. 287-297

  2. Pharmacokinetic/pharmacodynamic modelling of ciprofloxacin 250 mg/12 h versus 500 mg/24 h for urinary infections

    Journal of Antimicrobial Chemotherapy, Vol. 50, Núm. 1, pp. 67-72

  3. Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients

    Clinical Pharmacokinetics, Vol. 41, Núm. 14, pp. 1213-1220

2001

  1. Determination of ambroxol hydrochloride by HPLC

    Journal of Liquid Chromatography and Related Technologies, Vol. 24, Núm. 7, pp. 1007-1014

  2. Estudio por calorimetría diferencial de barrido (DSC) de la compatibilidad entre los componentes de una formulación oral líquida para administración oral

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 91, pp. 107-111

1999

  1. High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 721, Núm. 2, pp. 271-278

  2. In vitro study of the interaction between quinolones and polyvalent cations

    Pharmaceutica Acta Helvetiae, Vol. 73, Núm. 5, pp. 237-245

1995

  1. Calculation of partial components of bioavailability in slow release formulations using model-independent methods

    International Journal of Pharmaceutics, Vol. 117, Núm. 1, pp. 113-118

1992

  1. A Computer Program (DCN) for Numerical Convolution and Deconvolution of Pharmacokinetic Functions

    Journal of Pharmacobio-Dynamics, Vol. 15, Núm. 5, pp. 203-214

  2. A method for the calculation of bioavailability in slow release formulations in the presence of within-individual variability

    International Journal of Pharmaceutics, Vol. 86, Núm. 2-3, pp. 123-130

1991

  1. Bioequivalence of a new formulation of flecainide acetate.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 216-220

1989

  1. Pharmacokinetic and nephrotoxic study of gentamicin in rabbits using a new dosage regimen

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 14, Núm. 2, pp. 169-175

  2. Ultrastructural effects of gentamicin at therapeutic doses on the renal cortex

    Revista Espanola de Quimioterapia, Vol. 2, Núm. 1, pp. 73-77

1985

  1. In vitro adsorption-desorption of papaverine hydrochloride by montmorillonite

    Drug Development and Industrial Pharmacy, Vol. 11, Núm. 11, pp. 1909-1930